Revive Therapeutics Ltd (RVV.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 1 | 1 | 1 | 1 | 1 |
| Other Working Capital | 36 | 2 | -16 | -28 | 110 |
| Other Operating Activity | -407 | -239 | -270 | -267 | -476 |
| Operating Cash Flow | $-370 | $-236 | $-285 | $-294 | $-366 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 1 | -1 | N/A | N/A | 0 |
| Purchase Sale Intangibles | N/A | N/A | N/A | N/A | -9 |
| Other Investing Activity | -1 | -750 | 0 | 0 | 0 |
| Investing Cash Flow | $0 | $-751 | $N/A | $N/A | $-9 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 15 | N/A | N/A | N/A | 0 |
| Other Financing Activity | 0 | 1,335 | 0 | 0 | 148 |
| Financing Cash Flow | $15 | $1,335 | $N/A | $N/A | $148 |
| Beginning Cash Position | 830 | 481 | 767 | 1,061 | 1,287 |
| End Cash Position | 475 | 830 | 481 | 767 | 1,061 |
| Net Cash Flow | $-355 | $348 | $-285 | $-294 | $-227 |
| Free Cash Flow | |||||
| Operating Cash Flow | -370 | -236 | -285 | -294 | -366 |
| Capital Expenditure | N/A | N/A | N/A | N/A | -9 |
| Free Cash Flow | -370 | -236 | -285 | -294 | -375 |